Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2023 on Friday, May 5, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested.

Owens & Minor Announces First Quarter 2023 Earnings Release Date and Conference Call

Owens & Minor to Participate in Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference

Owens & Minor, Inc. (NYSE:OMI ) Q4 2022 Earnings Conference Call February 28, 2023 8:00 AM ET Company Participants Alex Jost - Director of Investor Relations Ed Pesicka - President and Chief Executive Officer Alex Bruni - Executive Vice President and Chief Financial Officer Conference Call Participants Michael Cherny - Bank of America Kevin Caliendo - UBS Lisa Gill - JPMorgan Evan Stover - Baird Operator Good morning. My name is Chris, and I'll be your conference operator today.

Owens & Minor, Inc. (OMI) Q4 2022 Earnings Call Transcript

Owens & Minor (OMI) delivered earnings and revenue surprises of -28.21% and 6.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Misses Q4 Earnings Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the fourth quarter and the year ended December 31, 2022, as summarized in the table below.

Owens & Minor Reports Fourth Quarter and Full Year 2022 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter and full year of 2022 on Tuesday, February 28, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. ET on the same day. Participants may ac

Owens & Minor Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for

RICHMOND, Va.--( BUSINESS WIRE )--Owens & Minor, Inc. (NYSE: OMI) announced today that executive leadership will participate in a virtual fireside chat at the upcoming 5th Annual Evercore ISI HealthCONx Conference. The discussion will take place on Wednesday, November 30 at 1:00 p.m. Eastern Time.

Owens & Minor to Participate in the 5th Annual Evercore ISI HealthCONx Conference

The Owens & Minor Foundation and Ronald McDonald House Charities Partner to Help Build Healthier Communities

Owens & Minor, Inc. (NYSE:OMI ) Q3 2022 Earnings Conference Call November 2, 2022 8:30 AM ET Corporate Participants Alex Jost - Director-Investor Relations Ed Pesicka - President and Chief Executive Officer Alex Bruni - Executive Vice President and Chief Financial Officer Conference Call Participants Andrea Alfonso - UBS Daniel Grosslight - Citi John Stansel - JPMorgan Charlotte Kolb - Bank of America Operator Good day and thank you for standing by. Welcome to Owens & Minor's Third Quarter 2022 Earnings Conference Call.

Owens & Minor, Inc. (OMI) Q3 2022 Earnings Call Transcript

Owens & Minor (OMI) delivered earnings and revenue surprises of 5.13% and 3.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Q3 Earnings and Revenues Beat Estimates

Owens & Minor Reports Third Quarter 2022 Financial Results

Earnings Preview: Owens & Minor (OMI) Q3 Earnings Expected to Decline

The Owens & Minor Foundation Announces Donation to National Association for Free and Charitable Clinics

The healthcare logistics company released preliminary third-quarter numbers that investors didn't like.

Why Owens & Minor Shares Plummeted 32.4% This Week

Delivering medical supplies to hospitals would seem to be a simple and successful recurring revenue business model, but it is not always that easy. The leader in this field is Owens & Minor Inc. ( OMI , Financial), a large global health care solutions company that integrates medical product manufacturing and delivery, home health supply and surgical-related services to support patient care in a hospital setting and in the home.

This Leading Medical Supply Distributor Is Facing Headwinds

Owens & Minor Announces Executive Leadership Team Changes

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor has opened up nominations for the Supplier Diversity Awards honoring Earl G. Reubel. Nominations are being accepted until Nov. 18.

Owens & Minor Issues Call for Nominations for Annual Supplier Diversity Awards

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor received two Vizient Supplier Awards in recognition of its exemplary performance and service.

Owens & Minor Receives Two Vizient Supplier Awards

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today that executive management will present at the 2022 Baird Global Healthcare Conference on Tuesday, September 13 at 12:15 p.m. Eastern Daylight Time. Please visit the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-presentations/ at least ten minutes in advance to view a live webcast of the presentation. A replay of the webcast can be accessed following the pr

Owens & Minor to Participate in the 2022 Baird Global Healthcare Conference

MINNEAPOLIS & RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), a leading global healthcare solutions company, and Allina Health, a not-for-profit healthcare system dedicated to enhancing the health of individuals, families and communities throughout Minnesota and western Wisconsin, today announced their renewed partnership and a new strategic collaboration to create a unique integrated service model for supply chain resiliency. The integrated service model is an evolution of

Allina Health and Owens & Minor Expand Partnership and Announce New Strategic Collaboration

Owens & Minor, Inc. (NYSE:OMI ) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Alex Jost – Director-Investor Relations Ed Pesicka – President and Chief Executive Officer Andy Long – Executive Vice President and Chief Financial Officer Conference Call Participants Kevin Caliendo – UBS Daniel Grosslight – Citi Hannah Lee – Bank of America Eric Coldwell – Robert W. Baird Operator Good day, and thank you for standing by.

Owens & Minor, Inc. (OMI) CEO Ed Pesicka on Q2 2022 Results - Earnings Call Transcript

Owens & Minor (OMI) delivered earnings and revenue surprises of 0% and 3.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Q2 Earnings Meet Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the second quarter ended June 30, 2022, as summarized in the table below. "I am very pleased with our performance in the second quarter, where the strength of our business model and the O&M business system helped us in the face of external conditions that continued to deteriorate over the quarter,” said Edward A. Pesicka, President and Chief Executive Officer. "Our Patient Direct segment

Owens & Minor Reports Second Quarter 2022 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor today announced the election of David R. Myers, VP of National Accounts, to the Bellwether League Foundation's Hall of Fame.

News for Owens & Minor Stock (OMI)